ATM and ATR inhibition increases radiosensitivity and cGAS-STING activation in prostate cancer
{{output}}
Despite the availability of multiple effective therapies for localized prostate cancer, many patients still progress to incurable metastasized castration resistant prostate cancer (mCRPC). About 23 % of mCRPC patients carry alterations in DNA damage response (... ...
